Nifedipine prevents iron accumulation and reverses iron-overload-induced dopamine neuron degeneration in the substantia nigra of rats.
ZeGang Ma, Yu Zhou, JunXia Xie
Index: Neurotox. Res. 22(4) , 274-9, (2012)
Full Text: HTML
Abstract
The mechanisms of iron accumulation in substantia nigra (SN) of Parkinson's diseases remain unclear. The objective of this study was to investigate effects of nifedipine on iron-overload-induced iron accumulation and neurodegeneration in SN of rats. By high performance liquid chromatography-electrochemical detection, tyrosine hydroxylase (TH) immunohistochemistry, and iron content array, we first quantified iron content and the number of dopamine neurons in SN of experimental rats treated with iron dextran. We further assessed effects of treatment with nifedipine. Our results showed that nifedipine treatment prevents iron dextran-induced dopamine depletion in the striatum. Consistently, we found that nifedipine restores the number of TH-positive neurons reduced by iron dextran overload and prevents increase of iron content in the SN. These results suggested that nifedipine may suppress iron toxicity in dopamine neurons and prevent neurodegeneration.
Related Compounds
Related Articles:
2013-06-01
[Exp. Hematol. 41(6) , 539-46, (2013)]
[Importance of the different i.v. iron generations for everyday medical practice].
2013-03-21
[MMW Fortschr. Med. 155 Suppl 1 , 18-24, (2013)]
Use of intravenous iron supplementation in chronic kidney disease: an update.
2013-01-01
[Iran. J. Kidney Dis. 7(1) , 9-22, (2013)]
2013-06-01
[Dtsch. Med. Wochenschr. 138(24) , 1312-7, (2013)]
Iron dextran treatment does not induce serum protein carbonyls in the newborn pig.
2012-01-01
[Animal 6(1) , 79-86, (2012)]